Imatinib vs Tofacitinib
Imatinib vs Tofacitinib: Overview
This comparison examines the pharmacological differences between Imatinib and Tofacitinib.
Mechanism of Action
Imatinib: Selective inhibitor of BCR-ABL, c-Kit, and PDGFR tyrosine kinases.
Tofacitinib: Pan-JAK inhibitor with preference for JAK1 and JAK3 blocking pro-inflammatory cytokine signaling.
Pharmacokinetics
Half-life: Imatinib — 18 hours; Tofacitinib — 3.2 hours.
Chemical Properties
Molecular Formula: Imatinib — C29H31N7O; Tofacitinib — C16H20N6O.
Molecular Weight: Imatinib — 493.6030 g/mol; Tofacitinib — 312.3700 g/mol.
Type: Imatinib — Small molecule; Tofacitinib — Small molecule.